📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Silaproline-bearing nirmatrelvir derivatives are potent inhibitors of the SARS-CoV-2 main protease highlighting the value of silicon-derivatives in structure-activity-relationship studies. (2025)

First Author: Laczi D

Attributed to: RapidFire Enhancement of Mass Spectrometry Capability Across the Biosciences funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ejmech.2025.117603

PubMed Identifier: 40220677

Publication URI: http://europepmc.org/abstract/MED/40220677

Type: Journal Article/Review

Volume: 291

Parent Publication: European journal of medicinal chemistry

ISSN: 0223-5234